Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Reproductive Sciences
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
1933719109343310v1
16/12/1153    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Norian, J. M.
Right arrow Articles by Catherino, W. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norian, J. M.
Right arrow Articles by Malik, M.
Right arrow Articles by Parker, C. Y.
Right arrow Articles by Joseph, D.
Right arrow Articles by Leppert, P. C.
Right arrow Articles by Segars, J. H.
Right arrow Articles by Catherino, W. H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Transforming Growth Factor B3 Regulates the Versican Variants in the Extracellular Matrix-Rich Uterine Leiomyomas

John M. Norian, MD*, Minnie Malik, PhD, Candace Y. Parker, MD, Doina Joseph, MS, Phyllis C. Leppert, MD, PhD, James H. Segars, MD, and William H. Catherino, MD, PhD

* To whom correspondence should be addressed. E-mail: jmnorian{at}yahoo.com.


  Abstract

Uterine leiomyoma are common, benign tumors that are enriched in extracellular matrix. The tumors are characterized by a disoriented and loosely packed collagen fibril structure similar to other diseases with disrupted Transforming growth factor {beta} (TGF-{beta}) signaling. Here we characterized TGF-{beta}3 signaling and the expression patterns of the critical extracellular matrix component versican in leiomyoma and myometrial tissue and cell culture. We also demonstrate the regulation of the versican variants by TGF-{beta}3. Using leiomyoma and matched myometrium from 15 patients, messenger RNA (mRNA) from leiomyoma and myometrium was analyzed by semiquantitative real time reverse transcription–polymerase chain reaction (RT-PCR), while protein analysis was done by western blot. Transforming growth factor {beta}3 transcripts were increased 4-fold in leiomyoma versus matched myometrium. Phosphorylated-TGF-{beta} RII and phosphorylated-Smad 2/3 complex were greater in leiomyoma as documented by Western blot. The inhibitor Smad7 transcripts were decreased 0.44-fold. The glycosaminoglycan (GAG)-rich versican variants were elevated in leiomyoma versus myometrial tissue: specifically V0 (4.27 ± 1.12) and V1 (2.01 ± 0.27). Treatment of leiomyoma and myometrial cells with TGF-{beta}3 increased GAG-rich versican variant expression 7 to 12 fold. Neutralizing TGF-{beta}3 antibody decreased the expression of the GAG-rich versican variants 2 to 8 fold in leiomyoma cells. Taken together, the aberrant production of excessive and disorganized extracellular matrix that defines the leiomyoma phenotype involves the activation of the TGF-{beta} signaling pathway and excessive production of GAG-rich versican variants.

First published on August 21, 2009, doi:10.1177/1933719109343310

Reproductive Sciences 2009;16:1153.

A more recent version of this article appeared on December 1, 2009

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?